Pay in 4 interest-free payments of $6.26 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
The available data concerns low numbers of exposed pregnancies and lack a clear description of maternal and treatment characteristics with potential effect on neonatal outcome such as maternal BMI, drug dose and trimester of exposure
Starting at therapeutic dose produces severe nausea in 6075% of patients
Because GLP-1 medications slow digestion, researchers have asked whether they might contribute to SIBO or similar less common conditions such as intestinal methanogen overgrowth (IMO)
What if we want to stop the medication later
Rodrigues et al
US$ 22.76
US$ 27.44
US$ 28.08
US$ 21.47
